Story thread · 2 reports / 2 sources
Moderna’s Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson’s drug
fortune.com · 3h · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
CI is pairing top AI and biotech minds on its board (plus an advisory role for OpenAI's Fidji Simo) as it tests models on a Novo Nordisk drug.
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.